past
centuri
intern
travel
commerc
conflict
around
world
caus
mass
human
movement
creat
borderless
world
addit
accord
unit
nation
high
commission
refuge
unhcr
report
releas
januari
huge
popul
becom
global
displac
basic
total
popul
concern
high
million
start
popul
like
increas
current
situat
mani
differ
region
middl
east
particular
taken
consider
henc
displac
popul
world
accord
januari
data
present
tabl
travel
popul
dynam
result
enhanc
distribut
communic
diseas
mani
infect
diagnos
travel
migrat
clinic
spectrum
divers
innoc
asymptomat
infect
sever
septic
shock
icu
admiss
may
high
immigr
popul
sinc
quit
suscept
infect
variou
reason
live
outdoor
open
crowd
exposur
low
temperatur
low
standard
environment
hygien
limit
avail
potabl
water
declin
nutrit
statu
interrupt
immun
program
lack
infect
control
prevent
local
health
care
set
alter
distribut
infect
among
displac
popul
obviou
african
southeast
asian
refuge
especi
health
infrastructur
broken
lead
outbreak
due
endem
infect
like
malaria
tuberculosi
vectorborn
infect
mening
hepat
basic
diarrheal
ill
upper
respiratori
tract
infect
predomin
communic
diseas
mani
part
world
among
refuge
accordingli
immigr
led
introduct
infecti
diseas
rare
encount
develop
nation
anymor
eg
louseborn
fever
europ
consequ
migrant
crisi
origin
mainli
middl
east
north
africa
increas
number
icu
admiss
among
migrant
due
commun
acquir
infect
compris
icu
admiss
routin
medic
practic
tuberculosi
malaria
lung
infect
viscer
leishmaniasi
enter
fever
hemorrhag
fever
import
common
etiolog
sever
infect
travel
migrant
focu
primarili
manag
specif
diseas
migrant
may
experi
varieti
mental
physic
tortur
along
inconveni
hardship
relat
migrat
infect
injuri
requir
icu
support
major
concern
emerg
medicin
pyogen
bacteria
clostridium
perfringen
enter
gramneg
rod
staphylococcu
aureu
streptococcu
pyogen
acinetobact
baumannii
driven
increas
number
wound
infect
need
icu
support
worldwid
addit
geograph
region
origin
import
limit
factor
correct
identif
etiolog
commun
acquir
infecti
syndrom
icu
develop
countri
particularli
africa
asia
tuberculosi
highli
endem
tuberculosi
basic
affect
poor
vulner
popul
migrant
like
contract
tuberculosi
addit
lung
infect
tuberculosi
observ
frequent
upon
migrat
high
risk
area
malaria
frequent
subsaharan
africa
hemorrhag
fever
common
select
part
africa
southeast
asia
caribbean
central
south
america
actual
malaria
known
strong
impact
displac
popul
human
histori
deserv
particular
attent
horribl
exampl
sepsi
sever
plasmodium
falciparum
malaria
contribut
pregnancyrel
death
migrant
northwestern
thailand
period
data
antenat
clinic
analyz
enter
fever
clinic
syndrom
caus
salmonella
typhi
paratyphi
sometim
result
sever
gastrointestin
symptom
sepsi
enter
fever
mostli
seen
overcrowd
impoverish
area
eg
south
asia
subsaharan
africa
limit
access
sanit
leishmania
parasit
transmit
bite
freeroam
phlebotomin
sand
fli
leishmaniasi
mostli
seen
across
mediterranean
coast
middl
east
central
asia
south
central
america
viscer
leishmaniasi
known
kalaazar
sever
potenti
fatal
form
diseas
also
among
refuge
travelrel
infect
acut
present
within
month
return
sever
infect
depend
etiolog
timeli
diagnosi
diseas
long
latent
period
chronic
infect
rare
shortterm
travel
usual
seen
live
abroad
born
oversea
assess
etiolog
sever
infect
travel
migrant
import
detail
clinic
histori
hand
geograph
region
travel
date
travel
place
visit
type
transport
layov
intermedi
stop
potenti
exposur
exot
diseas
bitesvectorsanim
activ
undertaken
travel
along
prophylaxi
vaccin
administ
preced
travel
likewis
time
onset
symptom
predisposit
infect
note
incub
period
aid
physician
differenti
diagnos
tabl
age
travel
also
relev
differenti
diagnosi
younger
travel
like
exot
infect
wherea
older
travel
like
sever
infect
due
underli
diseas
includ
pneumonia
besid
migrant
overal
health
statu
avail
access
healthcar
system
overal
socioeconom
condit
consumpt
contamin
water
food
contact
anim
occurr
insect
bite
diseas
epidem
determin
infecti
etiolog
hand
migrant
consid
increas
risk
hiv
hepat
possibl
due
sexual
violenc
improp
medic
instrument
patient
sever
sepsi
return
malaria
endogen
region
test
malaria
promptli
five
speci
plasmodia
p
falciparum
p
vivax
p
oval
p
malaria
p
knowlesi
caus
diseas
howev
p
falciparum
gener
highest
risk
develop
septic
shock
falciparum
malaria
progress
rapidli
sever
form
potenti
lethal
still
treatabl
infect
median
incub
period
p
falciparum
day
rang
day
wherea
p
vivax
p
oval
longer
rang
day
sever
month
although
malaria
gener
clear
pathognomon
sign
symptom
sever
p
falciparum
infect
may
present
renal
failur
jaundic
respiratori
failur
central
nervou
system
involv
laboratori
diagnosi
perform
examin
giemsastain
blood
film
wherev
possibl
supplementari
diagnost
test
rapid
diagnost
test
pcr
etc
anoth
common
tropic
infecti
diseas
transmit
mosquito
dengu
fever
dengu
hemorrhag
fever
dengu
shock
syndrom
seriou
form
arbovir
infect
incub
period
short
day
progress
seriou
state
mark
hemorrhag
manifest
coagulopathi
increas
vascular
permeabl
edema
effus
circulatori
collaps
laboratori
featur
suggest
dengu
infect
includ
thrombocytopenia
leucopenia
elev
level
liver
enzym
serolog
diagnosi
pcr
method
use
laboratori
diagnosi
chikungunya
viral
infect
transmit
human
bite
mosquito
character
febril
ill
conspicu
polyarthralgia
may
sever
laboratori
diagnosi
gener
skill
test
serum
detect
viru
viral
nucleic
acid
virusspecif
igm
neutral
antibodi
ebola
viru
diseas
evd
sever
often
fatal
diseas
human
transmit
peopl
wild
anim
spread
human
popul
close
contact
blood
secret
organ
bodili
fluid
infect
peopl
anim
difficult
distinguish
evd
exot
infect
travel
countri
eg
recent
central
west
africa
widespread
recent
ebola
transmiss
clear
indic
test
symptom
usual
develop
within
day
headach
weak
muscl
pain
vomit
diarrhea
abdomin
pain
hemorrhag
provid
clue
diagnosi
patient
stage
also
test
viru
revers
transcriptas
polymeras
chain
reaction
rtpcr
common
recommend
test
diagnosi
evd
antibodycaptur
enzymelink
immunesorb
assay
elisa
antigencaptur
detect
test
serum
neutral
test
electron
microscopi
viru
isol
cell
captur
diagnost
test
evd
test
issu
sensit
specif
robust
reproduc
ideal
test
yet
exist
lung
infect
pneumonia
mainli
caus
influenza
next
frequent
caus
sever
infect
migrant
return
travel
especi
east
asia
overal
viral
bacteri
pathogen
affect
travel
similar
gener
popul
classic
viral
pathogen
rhinoviru
respiratori
syncyti
viru
influenza
viru
parainfluenza
virus
human
metapneumoviru
measl
mump
adenoviru
sever
coronavirus
wellknown
bacteri
pathogen
streptococcu
pneumonia
mycoplasma
pneumonia
haemophilu
influenza
chlamydia
pneumonia
coxiella
burnettii
legionella
pneumophila
howev
novel
viral
pathogen
middl
east
respiratori
syndrom
mer
addit
coronavirus
swine
flu
avian
influenza
avian
influenza
etc
consid
return
travel
migrant
molecular
method
includ
pcr
provid
rapid
sensit
test
sometim
even
simultan
identifi
sever
infecti
agent
furthermor
rapid
serolog
test
avail
pathogen
like
l
pneumophila
group
streptococcu
microbiolog
cultur
sputum
blood
low
sensit
high
specif
bacteri
pathogen
pulmonari
tuberculosi
miliari
tuberculosi
caus
sever
infect
especi
migrant
includ
multipl
organ
dysfunct
septic
shock
tuberculin
skin
test
surrog
diagnost
modal
test
posit
howev
neg
skin
test
result
frequent
seen
miliari
form
tuberculosi
acidfast
smear
cultur
infect
tissu
fluid
drainag
infect
tissu
standard
diagnost
test
diagnosi
tuberculosi
molecular
test
avail
also
use
rapid
diagnosi
sever
simpl
format
propos
recent
year
typhoid
paratyphoid
fever
character
sustain
fever
abdomin
pain
diagnos
cultur
caus
microorgan
blood
cultur
posit
patient
stool
cultur
posit
case
bone
marrow
cultur
consid
complic
case
uncertainti
diagnosi
serolog
test
widal
test
limit
clinic
valu
endem
area
posit
test
result
may
origin
previou
infect
diagnosi
viscer
leishmaniasi
routin
laboratori
analys
use
howev
specif
diagnosi
serolog
enzymelink
immunosorb
assay
elisa
agglutin
indirect
fluoresc
antibodi
ifa
parasitolog
examin
molecular
test
use
antimicrobi
suscept
profil
identifi
bacteri
pathogen
carriag
multidrug
resist
pathogen
taken
consider
decis
make
empir
antimicrobi
therapi
drug
resist
tuberculosi
detect
rapidli
appropri
treatment
option
altern
second
third
line
antituberculosi
drug
fluoroquinolon
ethionamid
cycloserin
amikacin
linezolid
crucial
manag
multidrug
resist
tuberculosi
antimalari
therapi
consid
patient
histori
fever
return
malariaendem
region
antimalari
medic
start
patient
definit
malaria
diagnosi
howev
death
sever
malaria
basic
rule
rather
except
mortal
defin
particularli
cerebr
malaria
fall
appropri
antimalari
therapi
therefor
empir
treatment
might
initi
either
sever
p
falciparum
infect
suspect
clearli
identifi
altern
diagnosi
parenter
antimalari
therapi
essenti
initi
treatment
sever
malaria
cinchona
alkaloid
quinin
quinidin
artemisinin
deriv
artesun
artemeth
two
major
class
drug
parenter
treatment
artemisinin
deriv
clear
parasitemia
rapidli
effect
broader
rang
parasit
stage
speci
howev
artemisininbas
combin
therapi
wide
avail
cdc
recommend
parenter
quinidin
sever
malaria
case
intraven
intramuscular
artesun
administ
least
h
patient
toler
oral
medic
patient
receiv
h
parenter
therapi
minimum
toler
oral
therapi
treatment
must
complet
day
oral
artemisinbas
combin
therapi
treatment
viscer
leishmaniasi
liposom
amphotericin
b
activ
safe
drug
howev
pentaval
antimoni
drug
paromomycin
miltefosin
altern
agent
cost
avail
drug
remain
issu
develop
countri
henc
region
refuge
particular
manag
viral
infect
support
therapi
infect
prevent
control
measur
essenti
antivir
drug
avail
coronavirus
hemorrhag
virus
basic
oseltamivir
zanamavir
use
effect
sever
influenza
case
manag
enter
fever
antimicrobi
resist
endem
region
travel
kept
mind
import
multidrug
resist
strain
report
indian
subcontin
southeast
asia
includ
china
mexico
arabian
gulf
africa
uncompl
enter
fever
monotherapi
usual
appropri
parenter
therapi
ampicillin
trimethoprimsulfamethoxazol
chloramphenicol
fluoroquinolon
primari
choic
resist
pathogen
altern
therapi
includ
azithromycin
carbapenem
newer
fluoroquinolon
higher
dose
fluoroquinolon
combin
therapi
consid
initi
aggress
fluid
resuscit
vital
manag
strategi
fluid
resuscit
may
employ
colloid
crystalloid
crystalloid
gener
first
line
fluid
colloid
administ
addit
crystalloid
ill
shock
develop
suddenli
administr
colloid
theoret
effect
dengu
shock
syndrom
good
exampl
case
main
characterist
dengu
shock
syndrom
sudden
mark
increas
vascular
permeabl
larg
volum
intraven
fluid
need
overcom
risk
overload
colloid
might
prefer
acut
resuscit
howev
lack
convinc
evid
higher
cost
colloid
choic
still
controversi
appropri
fluid
challeng
fail
restor
hemodynam
stabil
vasopressor
therapi
initi
hemorrhag
fever
dissemin
intravascular
coagul
observ
transfus
coagul
factor
platelet
need
patient
bleed
gener
norepinephrin
dopamin
prefer
firstlin
vasopressor
agent
epinephrin
phenylephrin
vasopressin
consid
firstlin
agent
fail
glycem
control
mgdl
renal
replac
therapi
corticosteroid
therapi
import
adjunct
therapi
sepsi
human
recombin
activ
protein
c
apc
use
reduc
high
rate
death
sever
sepsi
septic
shock
howev
evid
suggest
apc
use
treat
patient
sever
sepsi
septic
shock
known
exist
addit
apc
associ
higher
risk
bleed
furthermor
sourc
control
import
issu
manag
septic
shock
drainag
infect
fluid
debrid
infect
soft
tissu
remov
infect
devic
foreign
bodi
main
element
sourc
control
manag
sever
sepsi
septic
shock
migrant
return
travel
involv
systemat
approach
evalu
patient
includ
basic
inform
geograph
distribut
infect
visit
region
concurr
activ
earli
goal
direct
therapi
mandatori
lifesav
diagnosi
septic
shock
note
travel
refuge
spectrum
infecti
agent
like
broader
regular
autochton
